Literature DB >> 9184385

Factor V Leiden is associated with repeated and recurrent unexplained fetal losses.

E Grandone1, M Margaglione, D Colaizzo, M d'Addedda, G Cappucci, G Vecchione, N Sciannamé, G Pavone, G Di Minno.   

Abstract

Activated protein C resistance (APCR) is responsible for most cases of familial thrombosis. The factor V missense mutation Arg506 > Gln (FV Leiden) has been recognized as the commonest cause of this condition. Recently, it has been suggested that APCR is associated with second trimester fetal loss. We investigated the distribution of FV Leiden in a sample (n = 43) of Caucasian women with a history of two or more unexplained fetal losses. A group (n = 118) of parous women with uneventful pregnancies from the same ethnical background served as control. We found the mutation in 7 cases (16.28%) and 5 controls (4.24%; p = 0.011). A statistically significant difference between women with only early fetal loss vs those with late events (p = 0.04) was observed. Our data demonstrate a strong association between FV Leiden and fetal loss. Furthermore, they indicate that late events are more common in these patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184385

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  24 in total

Review 1.  [Jugular vein thrombosis caused by hypercoagulability following in-vitro fertilization-activated protein C resistance and immobilization].

Authors:  K Stölzel; S Jovanovic; A E Albers
Journal:  HNO       Date:  2013-03       Impact factor: 1.284

2.  Impact of smoking during pregnancy on functional coagulation testing.

Authors:  Donna Dizon-Townson; Connie Miller; Valerija Momirova; Baha Sibai; Catherine Y Spong; George Wendel; Katharine Wenstrom; Philip Samuels; Steve Caritis; Yoram Sorokin; Menachem Miodovnik; Mary J O'Sullivan; Deborah Conway; Ronald J Wapner; Steven G Gabbe
Journal:  Am J Perinatol       Date:  2011-08-04       Impact factor: 1.862

3.  Evaluation of chromosomal abnormalities and common trombophilic mutations in cases with recurrent miscarriage.

Authors:  Ahmet Karatas; Recep Eroz; Mustafa Albayrak; Tulay Ozlu; Bulent Cakmak; Fatih Keskin
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

4.  Genetic thromobophilia in pregnancy: a case-control study among North Indian women.

Authors:  Lovejeet Kaur; Manju Puri; Shweta Kaushik; Mohinder Pal Sachdeva; Shubha Sagar Trivedi; Kallur Nava Saraswathy
Journal:  J Thromb Thrombolysis       Date:  2013-02       Impact factor: 2.300

Review 5.  Thrombophilia and its treatment in pregnancy.

Authors:  A Eldor
Journal:  J Thromb Thrombolysis       Date:  2001-09       Impact factor: 2.300

6.  Factor V R506Q mutation-Leiden: an independent risk factor for venous thrombosis but not coronary artery disease.

Authors:  N Irani-Hakime; H Tamim; G Elias; S Choueiry; R Kreidy; J L Daccache; W Y Almawi
Journal:  J Thromb Thrombolysis       Date:  2001-04       Impact factor: 2.300

7.  Inherited genetic markers for thrombophilia in northeastern Iran (a clinical-based report).

Authors:  Fatemeh Keify; Mohsen Azimi-Nezhad; Narges Zhiyan-Abed; Mojila Nasseri; Mohammad Reza Abbaszadegan
Journal:  Rep Biochem Mol Biol       Date:  2014-04

8.  Recurrent pregnancy loss and thrombophilia.

Authors:  Maristella D'Uva; Pierpaolo Di Micco; Ida Strina; Giuseppe De Placido
Journal:  J Clin Med Res       Date:  2010-02-26

Review 9.  The effect of factor V Leiden carriage on maternal and fetal health.

Authors:  Dena Bloomenthal; Peter von Dadelszen; Robert Liston; Laura Magee; Peter Tsang
Journal:  CMAJ       Date:  2002-07-09       Impact factor: 8.262

10.  Etiology of hypercoagulable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: new clinical target for antithrombotic therapy.

Authors:  Maristella D'Uva; Pierpaolo Di Micco; Ida Strina; Antonio Ranieri; Carlo Alviggi; Antonio Mollo; Francesca Fabozzi; Lucia Cacciapuoti; Maria Teresa Scotto di Frega; Mariateresa Iannuzzo; Giuseppe De Placido
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.